Literature DB >> 32980818

Increased risk of cancer in patients with retinal vein occlusion: a 12-year nationwide cohort study.

Min Seok Kim1, Joon Hee Cho2, Seong Jun Byun1, Chang-Mo Oh3, Kyu Hyung Park1, Sang Jun Park4.   

Abstract

AIMS: To investigate the association between incident retinal vein occlusion (RVO) and the subsequent development of cancer.
METHODS: In this nationwide population-based retrospective study using 2002-2013 National Health Insurance Service database which covers the entire South Korean population, 186 701 incident RVO patients and their 1:1 propensity-score matched controls were included. We defined the fixed cohort from January 1st, 2004 to December 31st, 2013; the cohort included patients who suffered incident RVO after entering the cohort and their matched controls, and excluded patients having any cancer history before entering the cohort. The association of RVO and cancer was assessed by time-varying covariate Cox regression models; Model 1 included RVO as a time-varying covariate, Model 2 included Model 1 plus demographic information and Model 3 included Model 2 and comorbidities.
RESULTS: RVO was associated with an increased risk of subsequent cancer (HR=1.29; 95% CI, 1.26-1.31 in Model 1), which was consistent in Models 2 and 3. The incidence rate of overall cancer during the study period was 25.55 (95% CI, 25.19-25.91) per 1000 person-years in the RVO group and 18.62 (95% CI, 18.46-18.79) per 1000 person-years in the control group. In the subgroup analysis, haematological malignancies showed the highest association with RVO (HR=1.65; 95% CI, 1.49-1.83).
CONCLUSION: Patients with RVO have an increased risk of subsequent cancer development even after adjusting for demographic factors and comorbidities. Further study is warranted to elucidate these associations to provide proper recommendations for RVO patients regarding the cancer screening. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Retina

Mesh:

Year:  2020        PMID: 32980818     DOI: 10.1136/bjophthalmol-2020-316947

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  2 in total

1.  Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition.

Authors:  William Foulsham; Benjeil Z Edghill; O D Julia Canestraro; Vicky Makker; Jason Konner; David H Abramson; Jasmine H Francis
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-08

2.  Hypercoagulability Testing and Hypercoagulable Disorders in Young Central Retinal Vein Occlusion Patients.

Authors:  Zujaja Tauqeer; Peter Bracha; Brendan McGeehan; Brian L VanderBeek
Journal:  Ophthalmol Retina       Date:  2021-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.